PeriviAble DeLiveries: ALIgning PArental aNd PhysiCian PrioritiEs (ALLIANCE)

Launched by MANCHESTER UNIVERSITY NHS FOUNDATION TRUST · Feb 22, 2022

Keywords

ClinConnect Summary

The ALLIANCE trial is studying how to improve conversations between healthcare professionals and parents who are facing the birth of very premature infants, specifically those born between 22 and 24 weeks of pregnancy. Many parents have shared that the information they receive about their options can vary greatly between different doctors and hospitals. This study aims to understand what key information should be shared during these important discussions, so parents can make informed decisions about their baby's care.

Parents with infants born at this very early stage of pregnancy may be eligible to participate in the trial. The researchers will conduct interviews with both parents and clinicians to identify what information is most important and how to communicate it effectively. Participants can expect to engage in discussions that will help shape better practices for future families facing similar situations. Overall, the goal of this study is to ensure that parents are empowered with the right information at a critical time, leading to more consistent and supportive care for their infants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Infants born at periviable gestation. For this study periviability is defined as 22+0 - 24+6 weeks gestation.
• Exclusion Criteria:
• • Infants \<22+0 or \>24+6 weeks gestation.
• • Specific inclusion and exclusion criteria apply to each phase of the study.